NXL
NXL
NASDAQ · Health Care

Nexalin Technology Inc

$0.36
-0.01 (-3.14%)
Financial Highlights (FY 2026)
Revenue
392.2K
Net Income
-17,691,207
Gross Margin
78.3%
Profit Margin
-4,509.3%
Rev Growth
+5.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 78.3% 78.3% 58.5% 58.5%
Operating Margin -4,596.7% -4,137.1% 15.6% 16.3%
Profit Margin -4,509.3% -4,283.8% 10.4% 11.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 392.2K 372.1K 3.31M 3.62M
Gross Profit 307.1K 291.4K 1.94M 2.12M
Operating Income -18,027,724 -15,395,152 514.6K 589.5K
Net Income -17,691,207 -15,107,777 342.9K 405.7K
Gross Margin 78.3% 78.3% 58.5% 58.5%
Operating Margin -4,596.7% -4,137.1% 15.6% 16.3%
Profit Margin -4,509.3% -4,283.8% 10.4% 11.2%
Rev Growth +5.4% +5.4% +22.5% +6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.24M 3.21M
Total Equity 3.39M 3.33M
D/E Ratio 0.95 0.96
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,010,528 -16,234,938 846.1K 883.2K
Free Cash Flow 192.0K 243.4K